SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 201.29+0.2%Nov 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (20519)5/11/1998 9:20:00 PM
From: Torben Noerup Nielsen  Read Replies (1) of 32384
 
Squetch,

I went back and re-read the earlier posting I got the numbers from and I was wrong. It said a total of 16,000 patients which matches your 500-1,000 new case in the US per year pretty well. But I'd guess that you can triple that to get a worldwide market (I'm looking only at the wealthy part of the world; the rest won't get treated no matter how good the drug is). So it could be a pretty reasonable little revenue stream.

Sure, it wasn't profitable for Seragen. Part of the reason was the manufacturing facility. But Ligand could use that for other things as well....

I'll withhold judgement for a bit. I am guessing that Robinson and crew know exactly what they are doing. Don't forget that they are sure to have a lot more at stake financially than most of us....

Cheers, Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext